404 results on '"Calò, Girolamo"'
Search Results
2. Nociceptin/Orphanin FQ receptor expression in primary human umbilical vein endothelial cells is not regulated by exposure to breast cancer cell media or angiogenic stimuli
3. Neuropeptide S Encodes Stimulus Salience in the Paraventricular Thalamus
4. The NOP antagonist BTRX-246040 increases stress resilience in mice without affecting adult neurogenesis in the hippocampus
5. In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl
6. Fluorescent opioid receptor ligands as tools to study opioid receptor function
7. Pharmacological characterization of naloxegol: In vitro and in vivo studies
8. Nociceptin/orphanin FQ receptor system blockade as an innovative strategy for increasing resilience to stress
9. Pharmacological Assays for Investigating the NOP Receptor
10. NOP-Targeted Peptide Ligands
11. Nociceptin/Orphanin FQ and Urinary Bladder
12. Effects of Stress Exposure to Pain Perception in Pre-Clinical Studies: Focus on the Nociceptin/Orphanin FQ–NOP Receptor System.
13. Blockade of nociceptin/orphanin FQ signaling facilitates an active copying strategy due to acute and repeated stressful stimuli in mice
14. Plant-derived peptides rubiscolin-6, soymorphin-6 and their c-terminal amide derivatives: Pharmacokinetic properties and biological activity
15. Synthesis, biological evaluation and docking studies of a novel class of sulfur-bridged diazabicyclo[3.3.1]nonanes
16. Effects of non-peptide nociceptin/orphanin FQ receptor ligands on methylphenidate-induced hyperactivity in mice: Implications for bipolar disorders
17. Modulation of Drosophila suzukii type 1 tyramine receptor (DsTAR1) by monoterpenes: a potential new target for next generation biopesticides
18. Detailed In Vitro Pharmacological Characterization of the Clinically Viable Nociceptin/Orphanin FQ Peptide Receptor Antagonist BTRX-246040
19. Genetic Deletion of the Nociceptin/Orphanin FQ Receptor in the Rat Confers Resilience to the Development of Drug Addiction.
20. Corrigendum to “Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: are astrocytes the crossroad?” [Eur. J. Pharmacol. 823 (2018) 79–86]
21. Dopamine D1 and D2 receptors mediate neuropeptide S-induced antinociception in the mouse formalin test
22. A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study
23. NOP agonist action of cebranopadol counteracts its liability to promote physical dependence
24. Nociceptin/orphanin FQ receptor agonists increase aggressiveness in the mouse resident-intruder test
25. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH2, a mu opioid receptor agonist biased toward β-arrestin
26. Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad?
27. Cyclopeptide Dmt-[D-Lys-p-CF3-Phe-Phe-Asp]NH2, a novel G protein-biased agonist of the mu opioid receptor
28. Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors
29. Activation of nociceptin/orphanin FQ receptors inhibits contextual fear memory reconsolidation
30. Synthesis and activity of opioid peptidomimetics with β2- and β3-amino acids
31. Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt1]N/OFQ(1-13)
32. In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations
33. Genetic and pharmacological evidence that endogenous nociceptin/orphanin FQ contributes to dopamine cell loss in Parkinson's disease
34. Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems
35. Synthesis, biological evaluation and structural analysis of novel peripherally active morphiceptin analogs
36. Synthesis of mixed MOR/KOR efficacy cyclic opioid peptide analogs with antinociceptive activity after systemic administration
37. The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor
38. Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity
39. Blockade of nociceptin/orphanin FQ receptor signaling reverses LPS-induced depressive-like behavior in mice
40. In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant
41. Acute and subchronic antinociceptive effects of nociceptin/orphanin FQ receptor agonists infused by intrathecal route in rats
42. Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5
43. Nociceptin/orphanin FQ and stress regulate synaptophysin expression in the rat fundic and colonic mucosa
44. Central adenosine A1 and A2A receptors mediate the antinociceptive effects of neuropeptide S in the mouse formalin test
45. Corrigendum to “Cyclopeptide Dmt-[D-Lys-p-CF3-Phe-Phe-Asp]NH2, a novel G protein-biased agonist of the mu opioid receptor” [Peptides 101 (2018) 227–233]
46. A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ
47. Neuropeptide S counteracts 6-OHDA-induced motor deficits in mice
48. Pharmacological characterization of endomorphin-2-based cyclic pentapeptides with methylated phenylalanine residues
49. Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors
50. Nociceptin/orphanin FQ receptor antagonists as innovative antidepressant drugs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.